Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Cronos Australia Ltd. ( (AU:VIT) ) has shared an update.
Vitura Health has announced the immediate departure of CEO Geoff Cockerill as the board seeks leadership better aligned with its push for improved financial and operational performance and the next phase of its transformation. Chief Revenue Officer Ryan Tattle will oversee day-to-day operations as interim leader, with all executive team members reporting to him, while non-executive director Shane Tanner steps into an Interim Executive Director role to support execution of performance improvement initiatives until at least 30 April 2026. The board has begun an advanced search for a new, execution-focused CEO, and confirmed that incoming CFO Andrew Cook, who brings more than two decades of senior international finance experience, will join the business earlier than expected on 9 February 2026. Chair Robert Iervasi said the company’s strategic priorities remain unchanged, emphasising operational excellence, financial discipline and consolidation of Vitura’s position as a trusted healthcare services provider, signalling continuity of strategy despite the top leadership reshuffle.
The most recent analyst rating on (AU:VIT) stock is a Hold with a A$0.06 price target. To see the full list of analyst forecasts on Cronos Australia Ltd. stock, see the AU:VIT Stock Forecast page.
More about Cronos Australia Ltd.
Vitura Health Limited is an ASX-listed diversified digital health business focused on healthcare services and technology-enabled treatment pathways. Through wholly owned subsidiary Burleigh Heads Cannabis, it operates Canview, a leading Australian online ecosystem connecting prescribers, patients, pharmacies and suppliers, distributing around 600 therapeutic products and devices from about 70 domestic and international brands. Canview is being developed as an end-to-end healthcare platform that integrates medicines wholesaling with multiple SaaS tools for inventory, invoicing, customer management, reporting and analytics, and links directly with doctors’ patient management systems and a network of roughly 4,700 pharmacies across Australia.
Average Trading Volume: 257,894
Technical Sentiment Signal: Sell
Current Market Cap: A$37.78M
See more insights into VIT stock on TipRanks’ Stock Analysis page.